[Corifollitropin alfa (Elonva®) for controlled ovarian stimulation in assisted human reproductive techniques]

Sunyer B, Almazán C, Paladio N
Record ID 32012000863
Authors' objectives: To analyse the available scientific evidence on the efficacy, safety and efficiency of corifollitropin alfa for controlled ovarian stimulation, used together with GnRH antagonists for the development of multiple follicles in women who participate in assisted human reproduction technique programmes.
Authors' recommendations: The results of the clinical trials do not show substantial advantages of corifollitropin alfa with respect to the treatment of reference. Despite the convenience and adherence to the treatment represented by the use of corifollitropin alfa, from the viewpoint of the public sector portfolio, the uncertainty regarding safety as well as the higher cost limit the potential advantages posed by its use as a substitute for FSHr during the first seven days of controlled ovarian hyperstimulation.
Project Status: Completed
Year Published: 2011
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Chorionic Gonadotropin
  • Peptides
  • Kinetics
  • Reproductive Techniques, Assisted
Organisation Name: Agencia de Qualitat i Avaluacio Sanitries de Catalunya
Contact Address: Antoni Parada, CAHTA, Roc Boronat, 81-95 (2nd floor), 08005 Barcelona, Spain, Tel. +34 935 513 928, Fax: +34 935 517 510
Contact Name: direccio@aatrm.catsalut.net / aparada@aatrm.catsalut.net
Contact Email: direccio@aatrm.catsalut.net / aparada@aatrm.catsalut.net
Copyright: Catalan Agency for Health Information, Assessment and Quality (CAHIAQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.